Mark Ramos is a Cardiology physician. OpenAlex indexes 58 publications with 817 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
965 S Beneva Rd
Intercoastal Cardiology
Sarasota, FL 342322401
Telephone
941-366-1888Provider last certified this registry record 18 Oct 2024.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202513 payments
- Merck Sharp & Dohme LLCProgram year20255 payments
- Amgen Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.4%Statin20.7%Atorvastatin Calcium57%Rosuvastatin Calcium34%Simvastatin7%Pravastatin Sodium3%Part D≥476 patientsBeta blocker16%Metoprolol Succinate48%Metoprolol Tartrate22%Sotalol12%Carvedilol12%Atenolol3%Nebivolol Hcl2%Sotalol Af1%Propranolol Hcl1%Acebutolol Hcl1%Part D<11 patients+ 20 more classes in this area
Blood & clotting
18.2%Factor Xa inhibitor16%Eliquis84%Xarelto16%Part D≥422 patientsP2Y12 inhibitor1.4%Clopidogrel92%Prasugrel Hcl8%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.8%SGLT2 inhibitor2.3%Farxiga63%Jardiance37%Part D≥51 patientsPotassium supplement1%Potassium Chloride100%Part D≥44 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”